ATS 2019: Video met Bita Haijan, Ciro, Horn
May 2019
ATS
benralizumab
obstructieve longaandoening
COPD-exacerbatie
Haijan
A2625 - A: Dose-Ranging Study (TERRANOVA) of Benralizumab for Moderate to Severe Chronic Obstructive Pulmonary Disease.
A2626: Benralizumab for Chronic Obstructive Pulmonary Disease: Results of the Phase III GALATHEA Trial.
Longarts Bita Haijan over de door haar geselecteerde publicaties:
Wilt u meer lezen? Log dan in.
Gerelateerde items
